阜丰集团（00546）：港股研究|公司点评|阜丰集团（00546.HK）：2025年业绩大幅增长，强化股东回报

Investment Rating - The investment rating for the company is "Buy" and it is maintained [9]. Core Insights - The company reported a revenue of 27.88 billion HKD for 2025, representing a year-on-year growth of 0.4%. The attributable net profit was 2.47 billion HKD, which is a 6.6% increase compared to the previous year. The total dividend per share for 2025 was 0.487 HKD, up from 0.40 HKD in 2024, with a payout ratio of 45% compared to 40% in 2024 [2][6]. - The company is a leader in the global monosodium glutamate (MSG) industry, with expectations for industry demand to increase as the major competitors finish their production expansions in 2024. The company is also expanding its overseas operations, particularly in Kazakhstan, which is expected to contribute to its performance starting in 2026 [9]. - The company experienced significant growth in sales volumes for MSG, threonine, and lysine, despite a decline in average selling prices. The sales volume for MSG reached 1.804 million tons, a 10.1% increase year-on-year, while the average price fell by 15.4% to 5,681 HKD per ton. The animal nutrition segment saw a gross profit of 2.5 billion HKD, a 23.0% increase, with threonine and lysine sales volumes growing by 31.1% and 30.4%, respectively [9]. Summary by Relevant Sections Financial Performance - Revenue for 2025 was 27.88 billion HKD, with a net profit of 2.47 billion HKD. The dividend per share increased to 0.487 HKD, with a payout ratio of 45% [2][6]. Business Segments - The food additives segment generated 13.389 billion HKD in revenue, down 6.8%, but the gross margin improved by 2.7 percentage points to 13.5%. The animal nutrition segment's gross profit rose to 2.5 billion HKD, with a gross margin of 23.7% [9]. - The high-end amino acids segment saw a revenue decline of 11.0%, while the colloid segment's revenue decreased by 32.5% [9]. Market Outlook - The company anticipates a recovery in product prices starting in early 2026, following a period of decline. Prices for MSG and amino acids have begun to rise, supported by improved demand and rising raw material costs [9].